Peyvandi F, Artoni A, Novembrino C et al (2021) Hemostatic alterations in COVID-19. Haematologica 106:1472–1475. https://doi.org/10.3324/haematol.2020.262634

Article  CAS  PubMed  Google Scholar 

Chen T, Wu D, Chen H et al (2020) Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 368:m1091

Article  PubMed  PubMed Central  Google Scholar 

Tang N, Bai H, Chen X et al (2020) Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 18:1094–1099. https://doi.org/10.1111/jth.14817

Article  CAS  PubMed  PubMed Central  Google Scholar 

Halaby R, Cuker A, Yui J et al (2021) Bleeding risk by intensity of anticoagulation in critically ill patients with COVID-19: A retrospective cohort study. J Thromb Haemost 19:1533–1545. https://doi.org/10.1111/jth.15310

Article  CAS  PubMed  Google Scholar 

National Institutes of Health (2021) Coronavirus Disease 2019 (COVID-19) Treatment Guidelines [Internet]. National Institutes of Health, Bethesda (MD)

Google Scholar 

Martinelli I, Ciavarella A, Abbattista M et al (2021) Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19. Intern Emerg Med 16:1223–1229. https://doi.org/10.1007/s11739-020-02585-9

Article  PubMed  PubMed Central  Google Scholar 

Ferguson J, Volk S, Vondracek T et al (2020) Anticoagulation and Mortality in Critically Ill Patients With Respiratory Failure From SARS-CoV-2: A Retrospective Cohort Study. J Clin Pharmacol 60:1411–1415. https://doi.org/10.1002/jcph.1749

Article  CAS  PubMed  Google Scholar 

Colling ME, Kanthi Y (2020) COVID-19-associated coagulopathy: An exploration of mechanisms. Vasc Med 25:471–478. https://doi.org/10.1177/1358863X20932640

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bandera A, Aliberti S, Gualtierotti R et al (2020) COVID-19 Network: the response of an Italian Reference Institute to research challenges about a new pandemia. Clin Microbiol Infect 26:1576–1578. https://doi.org/10.1016/j.cmi.2020.06.028

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schulman S, Angerås U, Bergqvist D et al (2010) Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost 8:202–204. https://doi.org/10.1111/j.1538-7836.2009.03678

Article  CAS  PubMed  Google Scholar 

Kaatz S, Ahmad D, Spyropoulos AC, Schulman S (2015) Subcommittee on Control of Anticoagulation. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost 13:2119–2126. https://doi.org/10.1111/jth.13140

Article  CAS  PubMed  Google Scholar 

Klok FA, Kruip MJHA, van der Meer NJM et al (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 191:145–147. https://doi.org/10.1016/j.thromres.2020.04.013

Article  CAS  PubMed  PubMed Central  Google Scholar 

Poli D, Antonucci E, Ageno W et al (2022) Thromboembolic Complications in COVID-19 Patients Hospitalized in Italian Ordinary Wards: Data from the Multicenter Observational START-COVID Register. TH Open 6:e251–e256

Article  PubMed  PubMed Central  Google Scholar 

Pieralli F, Pomero F, Corbo L et al (2023) Incidence of lower limb deep vein thrombosis in patients with COVID-19 pneumonia through different waves of SARS-CoV-2 pandemic: A multicenter prospective study. PLoS ONE 18:e0280247. https://doi.org/10.1371//journal.pone.0280247

Article  CAS  PubMed  PubMed Central  Google Scholar 

Katsoularis I, Fonseca-Rodríguez O, Farrington P, at al, (2022) Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study. BMJ 6(377):e069590. https://doi.org/10.1136/bmj-2021-069590

Article  Google Scholar 

Group WHOREAfC-TW, Sterne JAC, Murthy S et al (2020) Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA 324:1330–1341. https://doi.org/10.1001/jama.2020.17023

Article  CAS  Google Scholar 

Kaptein FHJ, Stals MAM, Grootenboers M et al (2021) Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave. Thromb Res 199:143–148

Article  CAS  PubMed  Google Scholar 

Zuily S, Lefèvre B, Sanchez OCOVI-DOSE, investigators. et al (2023) Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial. EClinicalMedicine 60:102031. https://doi.org/10.1016/j.eclinm.2023.102031

Article  PubMed  PubMed Central  Google Scholar 

Onder G, Rezza G, Brusaferro S (2020) Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA J Am Med Assoc 323:1775–1776. https://doi.org/10.1001/jama.2020.4683

Article  CAS  Google Scholar 

Corradini E, Ventura P, Ageno W et al (2021) Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI). Intern Emerg Med 16:1005–1015. https://doi.org/10.1007/s11739-021-02742-8

Article  PubMed  PubMed Central  Google Scholar